Literature DB >> 18159926

Effect of cholesterol on the release of amphotericin B from PEG-phospholipid micelles.

Ronak Vakil1, Glen S Kwon.   

Abstract

Micelles formed from PEG-DSPE solubilize high levels of the poorly water-soluble antifungal amphotericin B (AmB). AmB release from PEG-DSPE micelles is slow in buffer but remarkably rapid in the presence of bovine serum albumin (BSA). Sequential changes in the absorbance spectrum of AmB in PEG-DSPE micelles point to a rapid dissociation of incorporated drug in the presence of BSA. In this context, we have studied micelles formed from PEG-DSPE which coincorporate cholesterol (PEG-DSPE|cholesterol). (1)H NMR measurements point to a lower mobility of lipid in PEG-DSPE|cholesterol micelles compared to PEG-DSPE micelles. The absorbance spectrum of AmB incorporated in PEG-DSPE|cholesterol micelles is distinct from that in PEG-DSPE micelles, which may point to differences in the drug-micelle interaction. AmB release from PEG-DSPE|cholesterol micelles is slow in buffer and in the presence of BSA. The absorption spectrum of AmB in PEG-DSPE|cholesterol micelles remained unchanged in BSA, further supporting stable incorporation and the slow release from the carrier.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18159926     DOI: 10.1021/mp700081v

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  12 in total

1.  Polymer micelle formulations of proteasome inhibitor carfilzomib for improved metabolic stability and anticancer efficacy in human multiple myeloma and lung cancer cell lines.

Authors:  Lin Ao; Derek Reichel; Di Hu; Hyunyoung Jeong; Kyung Bo Kim; Younsoo Bae; Wooin Lee
Journal:  J Pharmacol Exp Ther       Date:  2015-08-26       Impact factor: 4.030

2.  Pharmacokinetics and nephrotoxicity of amphotericin B-incorporated poly(ethylene glycol)-block-poly(N-hexyl stearate l-aspartamide) micelles.

Authors:  Thomas A Diezi; Jody K Takemoto; Neal M Davies; Glen S Kwon
Journal:  J Pharm Sci       Date:  2010-12-23       Impact factor: 3.534

3.  Encapsulation and release of Amphotericin B from an ABC triblock fluorous copolymer.

Authors:  Jun-Pil Jee; Aaron McCoy; Sandro Mecozzi
Journal:  Pharm Res       Date:  2011-07-08       Impact factor: 4.200

4.  Enhanced stability of PEG-block-poly(N-hexyl stearate l-aspartamide) micelles in the presence of serum proteins.

Authors:  Thomas A Diezi; Younsoo Bae; Glen S Kwon
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

5.  Amphotericin B/sterol co-loaded PEG-phospholipid micelles: effects of sterols on aggregation state and hemolytic activity of amphotericin B.

Authors:  Thomas A Diezi; Glen Kwon
Journal:  Pharm Res       Date:  2011-12-01       Impact factor: 4.200

6.  Anticancer efficacy and toxicokinetics of a novel paclitaxel-clofazimine nanoparticulate co-formulation.

Authors:  Dwayne Koot; Duncan Cromarty
Journal:  Drug Deliv Transl Res       Date:  2015-06       Impact factor: 4.617

Review 7.  Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.

Authors:  Célia Faustino; Lídia Pinheiro
Journal:  Pharmaceutics       Date:  2020-01-01       Impact factor: 6.321

Review 8.  A critical review of lipid-based nanoparticles for taxane delivery.

Authors:  Lan Feng; Russell J Mumper
Journal:  Cancer Lett       Date:  2012-07-13       Impact factor: 8.679

9.  Pegylated phospholipids-based self-assembly with water-soluble drugs.

Authors:  Yiguang Wang; Ruiqi Wang; Xiaoyan Lu; Wanliang Lu; Chunling Zhang; Wei Liang
Journal:  Pharm Res       Date:  2009-12-22       Impact factor: 4.200

10.  In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer.

Authors:  Rajiv Kumar; Apurva Kulkarni; Dattatri K Nagesha; Srinivas Sridhar
Journal:  Theranostics       Date:  2012-07-31       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.